Edwards Lifesciences Corp (EW)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 4,625,000 | 4,302,000 | 3,983,600 | 3,305,700 | 3,233,600 |
| Revenue | US$ in thousands | 5,997,700 | 5,362,000 | 5,219,100 | 4,382,800 | 4,333,200 |
| Gross profit margin | 77.11% | 80.23% | 76.33% | 75.42% | 74.62% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $4,625,000K ÷ $5,997,700K
= 77.11%
Over the past five years, Edwards Lifesciences Corp has demonstrated a consistently high gross profit margin, ranging from 74.37% in 2019 to 79.93% in 2022. The company's gross profit margin experienced a slight decline to 77.02% in 2023. This indicates that Edwards Lifesciences effectively controls its production costs and maintains a strong pricing strategy, resulting in a relatively stable and healthy margin. Overall, the company's gross profit margin reflects its ability to generate substantial profits from sales after accounting for the direct costs associated with the production of its medical equipment and products.
Peer comparison
Dec 31, 2023